Cargando…
Downregulation of CPA4 inhibits non small–cell lung cancer growth by suppressing the AKT/c‐MYC pathway
Carboxypeptidase A4 (CPA4) is a member of the metallocarboxypeptidase family. A previous study indicated that CPA4 may participate in the modulation of peptide hormone activity and hormone‐regulated tissue growth and differentiation. However, the role of CPA4 in lung tumorigenesis remains unclear. O...
Autores principales: | Fu, Yangyang, Su, Lihuang, Cai, Mengsi, Yao, Boyang, Xiao, Sisi, He, Qinlian, Xu, Le, Yang, Lehe, Zhao, Chengguang, Wan, Tingting, Shao, Lianyou, Wang, Liangxing, Huang, Xiaoying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6851884/ https://www.ncbi.nlm.nih.gov/pubmed/31397502 http://dx.doi.org/10.1002/mc.23095 |
Ejemplares similares
-
Down‐regulation of MTHFD2 inhibits NSCLC progression by suppressing cycle‐related genes
por: Yu, Chang, et al.
Publicado: (2019) -
FGF21 attenuates pulmonary arterial hypertension via downregulation of miR‐130, which targets PPARγ
por: Wang, Meibin, et al.
Publicado: (2022) -
The emerging role of the piRNA/PIWI complex in respiratory tract diseases
por: Yao, Yizhu, et al.
Publicado: (2023) -
The Complete CPA Reference
por: Dauber, Nick
Publicado: (2012) -
Flubendazole Elicits Antitumor Effects by Inhibiting STAT3 and Activating Autophagy in Non-small Cell Lung Cancer
por: Xie, Xiaona, et al.
Publicado: (2021)